Repligen Q2 Adj. EPS $0.37 Misses $0.39 Estimate, Sales $182.000M Beat $174.831M Estimate

Repligen (NASDAQ: RGEN) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.39 by 5.85 percent. This is a 12.12 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $182.000 million which beat the analyst consensus estimate of $174.831 million by 4.10 percent. This is a 18.13 percent increase over sales of $154.073 million the same period last year.